PDCD1 and cancer: Given that increased CD8+ T cell infiltration has been associated with an improved response to anti-PD-1 immunotherapy agents in other forms of cancer, gene expression profiling and the interferon gamma gene expression signature assay have been developed to measure the degree of T cell activation [25,97,98,99].